NCT05171075 2025-12-19
MAGNOLIA
Anthos Therapeutics, Inc.
Phase 3 Active not recruiting
Clinical Trials
7 trialsNCT03139487 2020-01-06
PRIORITY
Asan Medical Center
Phase 2 Unknown
NCT00966277 2016-12-12
Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients
M.D. Anderson Cancer Center
Phase 4 Completed
NCT00003674 2016-07-13
Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00031837 2015-10-14
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
University of Rochester
Phase 3 Terminated
NCT00323011 2014-05-21
FOLFIRI + Bevacizumab With or Without Dalteparin in First Line Treatment of Advanced Colorectal Cancer
University of Southern California
Phase 2 Terminated
NCT00462852 2013-08-12
Gemcitabine With or Without Dalteparin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
National Cancer Institute (NCI)
Phase 2 Completed